14 Jun 2021 Precigen ActoBio announces positive topline results from Phase 1b/2a Study of AG019 ActoBiotics™ Member news
19 May 2021 Galapagos announces first patient enrolled in FILOSOPHY study to advance understanding of Jyseleca (filgotinib) effectiveness and safety in a real-world setting Member news
11 May 2021 Sequana Medical announces strong top-line results from RED DESERT alfapump DSR® study and expansion of DSR® development programme Member news
28 Apr 2021 Precirix partners with Evergreen to expand North American clinical trial supply Member news
22 Mar 2021 ViroVet successful with second vaccine based on new vaccine technology, Rega Institute assesses development of human version Member news
22 Mar 2021 Consortium led by eTheRNA immunotherapies awarded EU Commission TIGER Grant of EUR 6.9 million Member news
04 Mar 2021 Galapagos reports primary endpoint for the ongoing filgotinib MANTA and MANTA-RAy safety studies Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
